BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook
BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...
BioNTech SE (BNTX) Receives a Buy from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
Inquirer on MSN7h
COA flags P152-M idle freezers for vaccines
With the country entering a “postpandemic phase,” the Commission on Audit (COA) has warned that P152 million worth of ...
Armed robbery in Revesby3h
AI Model IDs Key Cancer-Fighting Immune Cells
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...
Jean Tirole : « Europe is in danger of becoming an extra
EXCLUSIVE. According to the Nobel Prize-winning economist, Europe needs to review its innovation policy, or it will disappear ...
Johns Hopkins Medicine16h
Computer Model Helps ID Cancer-Fighting Immune Cells Key to Immunotherapy
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
The Messenger17h
UK's Markey home to two breakthrough therapeutic cancer vaccine trials
The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the Markey Cancer Center ...